KF
TXG icon

Krilogy Financial’s 10x Genomics TXG Stock Holding History

Krilogy Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Sell
14,654
-1,712
-10% -$44.9K 0.02% 594
2026
Q1 		$413K Buy
16,366
+31
+0.2% +$620 0.01% 637
2025
Q4 		$368K Hold
16,335
– – 0.01% 655
2025
Q3 		$220K Buy
+16,335
New +$213K 0.01% 796

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Krilogy Financial's TXG Position: Q2 2026 in Review

Krilogy Financial reduced its 10x Genomics (TXG) stake by 10% in Q2 2026, selling an estimated $44.9K and leaving 14,654 shares worth $562K. The position accounts for 0.02% of the portfolio, ranked #594.

Krilogy Financial first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Krilogy Financial held 14,654 shares of 10x Genomics worth $562K as of Q2 2026.
  • Krilogy Financial sold 1,712 10x Genomics shares in Q2 2026, an estimated $44.9K.
  • 10x Genomics made up 0.02% of Krilogy Financial's portfolio in Q2 2026, its #594 holding.
  • Krilogy Financial first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.